T5	Treatment 26 36	infliximab
T7	Effect 56 153	production of granulocyte and neutrophil autoantibodies with resultant autoimmune agranulocytosis
T8	Drug 26 36	infliximab
T6	Adverse_event 46 55	triggered
E1	Adverse_event:T6